David Stump
Director/Board Member chez MACROGENICS, INC.
Fortune : 63 421 $ au 31/03/2024
Profil
David C.
Stump is currently an Independent Director at REGENXBIO, Inc. and MacroGenics, Inc. He is also a Trustee at Earlham College.
Previously, he served as an Independent Director at Dendreon Corp.
from 2010 to 2015 and at Sunesis Pharmaceuticals, Inc. from 2006 to 2021.
He was also an Independent Director at Portola Pharmaceuticals LLC.
In addition, he held the position of Vice President-Clinical Research at Genentech, Inc. from 1989 to 1999 and Executive Vice President-Research & Development at Human Genome Sciences, Inc. from 1999 to 2012.
He was an Associate Professor at the University of Vermont and a Trustee at Adventist HealthCare, Inc. Dr. Stump obtained his undergraduate degree from Earlham College and his doctorate degree from Indiana University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
REGENXBIO, INC.
0,01% | 01/04/2024 | 3 010 ( 0,01% ) | 63 421 $ | 31/03/2024 |
MACROGENICS, INC.
-.--% | 22/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Stump
Sociétés | Poste | Début |
---|---|---|
MACROGENICS, INC. | Director/Board Member | 19/09/2013 |
REGENXBIO INC. | Director/Board Member | 15/10/2015 |
Earlham College | Director/Board Member | 22/02/2010 |
Anciens postes connus de David Stump
Sociétés | Poste | Fin |
---|---|---|
VIRACTA THERAPEUTICS, INC. | Director/Board Member | 24/02/2021 |
DENDREON CORPORATION | Director/Board Member | 10/06/2015 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 01/12/2012 |
Adventist HealthCare, Inc.
Adventist HealthCare, Inc. Medical/Nursing ServicesHealth Services Adventist HealthCare, Inc. engages in the provision of health care services. It offers bariatric surgery, behavioral health, cardiology, chronic wound care, cancer care, pediatrics, radiology, rehabilitation, senior living and home health care services. The company was founded in 1907 and is headquartered in Gaithersburg, MD. | Director/Board Member | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/01/1999 |
Formation de David Stump
Earlham College | Undergraduate Degree |
Indiana University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
REGENXBIO INC. | Health Technology |
MACROGENICS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Adventist HealthCare, Inc.
Adventist HealthCare, Inc. Medical/Nursing ServicesHealth Services Adventist HealthCare, Inc. engages in the provision of health care services. It offers bariatric surgery, behavioral health, cardiology, chronic wound care, cancer care, pediatrics, radiology, rehabilitation, senior living and home health care services. The company was founded in 1907 and is headquartered in Gaithersburg, MD. | Health Services |